Marathon Partners Equity Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-50,000
Closed -$131K 21
2025
Q1
$131K Hold
50,000
0.13% 18
2024
Q4
$191K Buy
+50,000
New +$270K 0.17% 26
2023
Q4
$3.62M Buy
517,000
+394,500
+322% +$2.62M 5.65% 7
2023
Q3
$973K Buy
122,500
+15,000
+14% +$94.6K 1.48% 17
2023
Q2
$596K Buy
107,500
+87,500
+438% +$480K 0.74% 22
2023
Q1
$114K Sell
20,000
-30,000
-60% -$199K 0.15% 31
2022
Q4
$350K Sell
50,000
-100,000
-67% -$1.03M 0.54% 24
2022
Q3
$1.34M Buy
+150,000
New +$1.73M 2.11% 11

Other funds holding MSOS

Marathon Partners Equity Management's MSOS Position: Q2 2025 in Review

Marathon Partners Equity Management sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q2 2025, closing a stake of 50,000 shares — an estimated $131K sold.

Marathon Partners Equity Management first reported a position in MSOS in Q3 2022 and held it in 8 quarters. The position peaked at $3.62M in Q4 2023. 151 funds tracked by Wall St. Rank hold MSOS as of Q2 2025.

  • Marathon Partners Equity Management reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q2 2025 after selling out during the quarter.
  • Marathon Partners Equity Management sold 50,000 AdvisorShares Pure US Cannabis ETF shares in Q2 2025, an estimated $131K.
  • Marathon Partners Equity Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q3 2022 and held it in 8 quarters.
  • Marathon Partners Equity Management's AdvisorShares Pure US Cannabis ETF position peaked at $3.62M in Q4 2023.
  • 151 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2025.

Based on Marathon Partners Equity Management's 13F filing for Q2 2025, filed 14 Aug 2025.